1Hamano H,Kawa S, Horiuchi A, et al. High serum IgG4 concentra-tions in patients with sclerosing pancreatitis [ J]. N Engl J Med,2001,344(10):732 -738.
2Yoshida K,Toki F,Takeuchi T,et al. Chronic pancreatitis caused byan autoimmune abnormality. Proposal of the concept of autoimmunepancreatitis [ J] . Dig Dis Sci,]995 ,40(7) ; 1561 - 1568.
3Frulloni L,Gabbrielli A, Pezzilli R, et al. Chronic pancreatitis: Re-port from a multicenter italian survey ( pancroinfaisp) on 893 pa-tienls[J]. Dig Liver Dis,2009 ,41 (4) :311 -317.
5Chari ST, Kloeppel G, Zhang L, et al. Histopathologic and clinicalsubtypes of autoimmune pancreatitis: The honolulu consensus docu-ment [J]. Pancreatology ,2010,10(6) : 664 - 672.
6Kamisawa T, Okamoto A, Wakabayashi T, et al. Appropriate steroidtherapy for autoimmune pancreatitis based on long-term outcome[J] . Scand J Gastroenterol ,2008 ,43 (5) :609 - 613.
7Tomiyama T, Uchida K, Matsushita M, et al. Comparison of steroidpulse therapy and conventional oral steroid therapy as initial treat-ment for autoimmune pancreatitis [ J]. J Gastroenterol, 2011,46(5):696 -704.
8Kamisawa T, Okazaki K, Kawa S, et al. Japanese consensus guide-lines formanagement of autoimmune pancreatitis : Iii. Treatment andprognosis of aip[ J] . J Gastroenterol,2010,45(5 ) :471 -477.
